ArticleJournal of gastrointestinal oncology2025
Multimodal imaging in hepatic epithelioid angiomyolipoma: a case report.
Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hepatic Epithelioid Angiomyolipoma: A Case Report.Cureus · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatic epithelioid angiomyolipoma (HEAML) is a rare mesenchymal neoplasm that can occasionally exhibit malignant behavior, such as postoperative recurrence or distant metastasis. Most HEAML patients are female, and it is difficult to distinguish them from other liver tumors. The diagnostic accuracy rate is less than 32%. We present a case of HEAML in an elderly woman with mild fatty liver, without a history of hepatitis, tuberculosis. The patient underwent early laparoscopic liver tumor resection. Case Description: A 69-year-old woman presented with intermittent right upper abdominal discomfort. Imaging revealed an ovoid liver mass. She was in good overall health, with no history of chronic diseases, hepatitis, tuberculosis, allergies, surgeries, trauma, or blood transfusions. Laboratory tests were normal, with negative results for carcinoembryonic antigen and alpha-fetoprotein (AFP). After computed tomography (CT) and magnetic resonance imaging (MRI) examinations, the patient underwent laparoscopic liver tumor resection. Conclusions: HEAML, the rare tumor, with a degree of malignant potential, predominantly affects elderly women. Certain characteristics on CT and MRI facilitate its differentiation from other intrahepatic lesions. In our case, a multimodal approach was utilized, and detailed imaging analysis of the tumor may serve as a reference for its accurate diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.